Patents Assigned to KLOGENIX LLC
  • Patent number: 11866469
    Abstract: The present disclosure relates to compositions and methods for modulating gene expression and in particular to DNA binding proteins and their use for increasing expression of Klotho. In some examples, the present disclosure provides an isolated or recombinant DNA binding protein comprising or attached to a transcriptional activation domain wherein the DNA binding protein binds to a target sequence within or near a Klotho gene.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: January 9, 2024
    Assignee: Klogenix LLC
    Inventor: Ci-Di Chen
  • Patent number: 11807850
    Abstract: The present disclosure relates to compositions and methods for modulating gene expression and in particular to compositions and methods for increasing expression of Klotho. For example, the present disclosure provides methods for increasing expression of a Klotho gene in a human cell comprising introducing into the cell a CRISPR enzyme and a guide RNA comprising a guide sequence that is substantially complementary to a target sequence within or near the Klotho gene, wherein the guide RNA or the CRISPR enzyme associates with a transcriptional activation domain.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: November 7, 2023
    Assignee: KLOGENIX LLC
    Inventors: Ci-Di Chen, Ella Zeldich, Carmela Abraham